cetylpyridinium has been researched along with Mucopolysaccharidosis IV in 2 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
Mucopolysaccharidosis IV: Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tønnesen, T | 1 |
Gregersen, HN | 1 |
Güttler, F | 1 |
Orii, T | 1 |
Yamaguchi, M | 1 |
Minami, R | 1 |
Ito, H | 1 |
Nakao, T | 1 |
2 other studies available for cetylpyridinium and Mucopolysaccharidosis IV
Article | Year |
---|---|
Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux-Lamy phenotype.
Topics: Adult; Cells, Cultured; Cetylpyridinium; Chondro-4-Sulfatase; Dermatan Sulfate; Diagnostic Errors; F | 1991 |
Influence of fresh plasma infusions on patients with genetic mucopolysaccharidosis.
Topics: Adolescent; Blood Transfusion; Cetylpyridinium; Child; Corneal Opacity; Creatinine; Female; Glycosam | 1974 |